MeSH term
Frequency | Condition_Probility | Adult | 6 | 0.0 |
Aged | 6 | 0.0 |
Alleles | 5 | 0.0 |
Female | 9 | 0.0 |
Genotype | 6 | 0.0 |
Glucuronosyltransferase/*genetics | 7 | 6.0 |
Humans | 35 | 0.0 |
Japan | 3 | 0.0 |
Male | 10 | 0.0 |
Middle Aged | 8 | 0.0 |
*Polymorphism, Genetic | 6 | 0.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 23 | 0.0 |
Animals | 12 | 0.0 |
Cell Line | 6 | 0.0 |
Chromatography, High Pressure Liquid | 6 | 0.0 |
Glucuronides/*metabolism | 3 | 18.0 |
Glucuronosyltransferase/*metabolism | 7 | 12.0 |
In Vitro | 5 | 0.0 |
Isoenzymes/metabolism | 2 | 0.0 |
Microsomes/enzymology/*metabolism | 2 | 33.0 |
Recombinant Proteins/metabolism | 5 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
Exons | 4 | 0.0 |
Polymorphism, Genetic/*genetics | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 15 | 0.0 |
Glucuronides/metabolism | 6 | 14.0 |
Metabolic Detoxication, Drug | 2 | 2.0 |
Spectrum Analysis, Mass | 2 | 0.0 |
Stereoisomerism | 2 | 0.0 |
Substrate Specificity | 5 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Glucuronosyltransferase/*genetics/*metabolism | 2 | 28.0 |
Polymerase Chain Reaction | 5 | 0.0 |
African Continental Ancestry Group/genetics | 2 | 0.0 |
Carcinogens/*pharmacokinetics | 2 | 8.0 |
Comparative Study | 7 | 0.0 |
European Continental Ancestry Group/genetics | 2 | 0.0 |
Genetic Predisposition to Disease | 2 | 0.0 |
Liver/enzymology | 3 | 0.0 |
Organ Specificity | 2 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Catalysis | 6 | 0.0 |
Kinetics | 8 | 0.0 |
Risk Factors | 2 | 0.0 |
Glucuronosyltransferase/genetics/*metabolism | 3 | 8.0 |
Isoenzymes/genetics/metabolism | 2 | 1.0 |
Mice | 2 | 0.0 |
Base Sequence | 3 | 0.0 |
Glucuronosyltransferase/*genetics/metabolism | 3 | 12.0 |
Cells, Cultured | 3 | 0.0 |
*Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Rats | 5 | 0.0 |
Transfection | 5 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
COS Cells | 4 | 0.0 |
Molecular Sequence Data | 5 | 0.0 |
Rabbits | 3 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Variation (Genetics) | 2 | 0.0 |
Blotting, Western | 2 | 0.0 |
Amines/*metabolism | 2 | 11.0 |
Cloning, Molecular | 2 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Gene Expression Regulation, Enzymologic | 3 | 0.0 |
Glucuronates/*metabolism | 4 | 19.0 |
Glucuronosyltransferase/chemistry/genetics/*metabolism | 3 | 60.0 |
Imipramine/*metabolism | 2 | 66.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Haplotypes | 2 | 0.0 |
Flavonoids/*metabolism | 2 | 33.0 |
Mutation, Missense | 2 | 0.0 |
Microsomes, Liver/metabolism | 3 | 1.0 |
